lncRNA RPPH1 promotes non‑small cell lung cancer progression through the miR‑326/WNT2B axis
- Yuying Wu
- Kewei Cheng
- Wenjun Liang
- Xiaohua Wang
Affiliations: Department of Respiratory and Critical Care Medicine, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu 213000, P.R. China
- Published online on: August 10, 2020 https://doi.org/10.3892/ol.2020.11966
Copyright: © Wu
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Long non‑coding RNAs (lncRNAs) serve important regulatory roles in human tumors. The aim of the present study was to examine the role of ribonuclease P RNA component H1 (RPPH1) in non‑small cell lung cancer (NSCLC). RPPH1 expression was assessed in datasets from The Cancer Genome Atlas, as well as lung cancer cell lines and patients with NSCLC. RPPH1 was significantly upregulated in NSCLC cell lines, compared with a normal lung epithelial cell line. Moreover, high RPPH1 expression was associated with poor overall survival and disease progression. RPPH1 was knocked down in A549 and H1299 cells using short hairpin (sh) RNA constructs, and the expressions of target genes and proteins were determined by reverse transcription‑quantitative PCR and western blotting. Cell invasion potential was also determined using Transwell Matrigel assays. Compared with the negative control, RPPH1 silencing significantly reduced the number of invading cells, increased E‑cadherin expression and reduced vimentin protein expression. Cell resistance to cisplatin/cis‑diamminedichloridoplatinum (CDDP) was also evaluated using Cell Counting Kit‑8 and colony formation assays. RPPH1 overexpression increased the resistance of A549 and H1299 cells to CDDP. Moreover, the potential interactions between RPPH1, microRNA (miR)‑326 and Wnt family member 2B (WNT2B) were investigated using luciferase reporter assays and co‑transfection experiments. MiR‑326 expression was directly inhibited by RPPH1. In A549 cells co‑transfected with shRPPH1 and miR‑326 inhibitor, the invading cell number significantly increased compared with cells transfected with shRPPH1 alone. In addition, E‑cadherin expression levels were reduced, and vimentin was upregulated. MiR‑326 overexpression partially reduced the resistance of A549 cells to CDDP induced by RPPH1 overexpression. WNT2B expression was directly suppressed using miR‑326. A549 cells co‑transfected with a miR‑326 mimic and a WNT2B overexpression vector demonstrated increased invasion potential, reduced E‑cadherin and increased vimentin protein expression levels, compared with cells transfected with the mimic alone. miR‑326 overexpression reduced CDDP resistance in A549 cells. However, co‑transfection with WNT2B partially enhanced CDDP resistance, compared with the mimic alone. In conclusion, RPPH1 promoted NSCLC progression and lung cancer cell resistance to CDDP through miR‑326 and WNT2B.